Pharmaceutical companies in India have been subject to more scrutiny and oversight by the U.S. Food and Drug Administration due to recent events of bad practice at a handful of facilities, according to a report by The New York Times.
Read the full story on Becker’s Hospital Review.
More Articles on Pharmaceuticals:
Salix Pharmaceuticals Acquires Santarus
Abrams Royal Pharmacy Issues Voluntary Recall on All Unexpired Sterile Products
Valeant Pharmaceuticals International to Acquire Solta Medical for $250M
Recommended Live Webinar on Mar 24, 2026 12:00 PM - 1:00 PM CST